MEMO, Maurizio
 Distribuzione geografica
Continente #
NA - Nord America 19.362
EU - Europa 9.092
AS - Asia 4.424
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 27
AF - Africa 25
SA - Sud America 22
Totale 32.981
Nazione #
US - Stati Uniti d'America 19.270
PL - Polonia 2.752
CN - Cina 2.684
UA - Ucraina 2.228
DE - Germania 1.087
IT - Italia 983
HK - Hong Kong 670
FI - Finlandia 561
GB - Regno Unito 479
IE - Irlanda 398
SG - Singapore 396
IN - India 373
FR - Francia 252
VN - Vietnam 135
SE - Svezia 94
CA - Canada 88
BE - Belgio 73
RU - Federazione Russa 67
TR - Turchia 52
CZ - Repubblica Ceca 48
IR - Iran 48
EU - Europa 27
AU - Australia 26
BR - Brasile 15
NL - Olanda 15
KR - Corea 14
MU - Mauritius 12
ES - Italia 11
JP - Giappone 8
BG - Bulgaria 7
HU - Ungheria 7
PH - Filippine 6
RO - Romania 6
TW - Taiwan 6
AT - Austria 5
IL - Israele 5
TH - Thailandia 5
CL - Cile 4
EE - Estonia 4
EG - Egitto 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
BD - Bangladesh 3
CH - Svizzera 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
SD - Sudan 3
AR - Argentina 2
BA - Bosnia-Erzegovina 2
DK - Danimarca 2
ET - Etiopia 2
GR - Grecia 2
MX - Messico 2
PT - Portogallo 2
AM - Armenia 1
AZ - Azerbaigian 1
FK - Isole Falkland (Malvinas) 1
GH - Ghana 1
ID - Indonesia 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
MS - Montserrat 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
TN - Tunisia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 32.981
Città #
Fairfield 3.138
Warsaw 2.752
Woodbridge 2.436
Houston 1.738
Jacksonville 1.634
Ann Arbor 1.374
Ashburn 1.338
Seattle 1.242
Cambridge 1.221
Wilmington 1.034
Chandler 818
Princeton 705
Hong Kong 660
Nanjing 599
Beijing 405
Dublin 396
Brescia 389
Helsinki 304
New York 285
Dearborn 234
Singapore 219
Nanchang 216
Shenyang 188
Des Moines 174
San Diego 170
Hebei 156
Jinan 144
Changsha 134
Dong Ket 133
Milan 121
Shanghai 107
Tianjin 106
Lancaster 93
Jiaxing 80
Brussels 72
San Mateo 72
Hangzhou 70
Ningbo 65
Zhengzhou 60
Kunming 59
Pune 57
Toronto 52
Verona 51
Augusta 50
London 50
Haikou 45
Leawood 45
San Francisco 42
Ardabil 41
West Jordan 40
Brno 38
Norwalk 36
Taizhou 35
Monmouth Junction 32
Lanzhou 31
Kocaeli 30
Los Angeles 29
Taiyuan 28
Boardman 27
Guangzhou 27
Munich 27
Kilburn 25
Phoenix 22
Fuzhou 20
Orange 20
Hefei 18
Rome 18
Napoli 13
North York 13
Redwood City 13
Melbourne 12
Changchun 10
Nürnberg 10
Paris 10
Acton 9
Canberra 9
Mascalucia 9
Olomouc 9
Chiswick 8
Mumbai 8
Naples 8
Padova 8
Bergamo 7
Berlin 7
Bologna 7
Falls Church 7
Hounslow 7
Lappeenranta 7
Leipzig 7
New Bedfont 7
Prescot 7
Qingdao 7
Seoul 7
Barcelona 6
Brooklyn 6
Central District 6
Fremont 6
Ottawa 6
Taipei 6
Wandsworth 6
Totale 26.345
Nome #
Advanced Glycation end products (AGEs) in food: focusing on Mediterranean pasta 383
Wireless Point-of-Care Platform With Screen-Printed Sensors for Biomarkers Detection 331
"RaMassays": Synergistic Enhancement of Plasmon-Free Raman Scattering and Mass Spectrometry for Multimodal Analysis of Small Molecules 312
Mitochondrial Alterations in Peripherla Mononuclear Blood Cells from Alzheimer's Disease and Mild Cognitive Impairment Patients 308
Comparison of extracellular and intracellular blood compartments highlights redox alterations in Alzheimer's and Mild Cognitive Impairment patients. 299
Notch ligand Delta-like 1 as a novel molecular target in childhood neuroblastoma 283
Ferrous Iron Up-regulation in Fibroblasts of Patients with Beta Propeller Protein-Associated Neurodegeneration (BPAN). 268
Nutrition and AGE-ing: Focusing on Alzheimer’s Disease 252
Characterization of the Antioxidant Effects of γ-Oryzanol: Involvement of the Nrf2 Pathway 250
Conformational altered p53 affects neuronal function: relevance for the response to toxic insult and growth-associated protein 43 expression 248
Methylxanthines induce structural and functional alterations of the cardiac system in zebrafish embryos 246
Conformational altered p53 as an early marker of oxidative stress in Alzheimer's disease. 243
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity 231
Favorable prognostic role of tropomodulins in neuroblastoma 222
Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes 220
Priming of cultured neurons with sabeluzole results in long-lasting inhibition of neurotoxin-induced tau expression and cell death. 219
Gamma-oryzanol prevents LPS-induced brain inflammation and cognitive impairment in adult mice 218
Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease. 209
Cortical Structure Alterations and Social Behavior Impairment in p50-Deficient Mice 208
Adrenocortical carcinoma xenograft in zebrafish embryos as model to study the in vivo cytotoxicity of abiraterone acetate 208
Clinical potentials of human pluripotent stem cells 196
y-Oryzanol improves cognitive function and modulates hippocampal proteome in mice 194
Monitoring Caco-2 to enterocyte-like cells differentiation by means of electric impedance analysis on printed sensors 191
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. 182
Zebrafish larvae as a behavioral model in neuropharmacology. 175
Redox homeostasis and natural dietary compounds: Focusing on antioxidants of rice (oryza sativa L.) 171
Cytoskeletal protection: acting on notch to prevent neuronal dysfunction. 148
Dietary zeolite supplementation reduces oxidative damage and plaque generation in the brain of an Alzheimer's disease mouse model. 147
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 145
Melanocortin 4 receptor stimulation improves social deficits in mice through oxytocin pathway 144
Genetic Polymorphisms as Possible Factors Involved in the Onset of Anthracycline-Induced Cardiomyopathy 142
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 142
Sulphurous thermal water increases the release of the anti-inflammatory cytokine IL-10 and modulates antioxidant enzyme activity. 139
CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation 138
Enhanced sensing of interleukin 8 by stripping voltammetry: Carbon nanotubes versus fullerene 138
Cannabinoids in health and disease: Pharmacological potential in metabolic syndrome and neuroinflammation 132
Palbociclib inhibits proliferation of human adrenocortical tumor cells 131
An Integrated Approach for a Structural and Functional Evaluation of Biosimilars: Implications for Erythropoietin 130
A mechanism additional to cyclic AMP accumulation for vasoactive intestinal peptide-induced prolactin release. 126
Inhibition of Survivin Is Associated with Zoledronic Acid-induced Apoptosis of Prostate Cancer Cells 126
Protein nitration profile of CD3+ lymphocytes from Alzheimer disease patients: Novel hints on immunosenescence and biomarker detection 126
The role of chirality in a set of key intermediates of pharmaceutical interest, 3-aryl-substituted-γ-butyrolactones, evidenced by chiral HPLC separation and by chiroptical spectroscopies 126
Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. 125
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 124
N-methyl-D-aspartate neurotoxicity in hippocampal slices: protection by aniracetam. 124
Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines 123
Identification and characterization of a kappa B/Rel binding site in the regulatory region of the amyloid precursor protein gene. 122
A Tau antisense oligonucleotide decreases neurone sensitivity to excitotoxic injury. 122
Cellular mechanisms for neurotensin receptor-mediated release of prolactin. 122
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity 122
Dopamine receptor agonists for protection and repair in Parkinson's disease. 121
Activation of dopamine D2 receptors linked to voltage-sensitive potassium channels reduces forskolin-induced cyclic AMP formation in rat pituitary cells. 121
null 121
mGluR5 metabotropic glutamate receptor distribution in rat and human spinal cord: a developmental study. 119
Zeolite clinoptilolite: Therapeutic virtues of an ancient mineral 118
Antisense strategy unravels tau proteins as molecular risk factors for glutamate-induced neurodegeneration. 117
Management of Severe Cushing Syndrome Induced by Adrenocortical Carcinoma with Abiraterone Acetate: A Case Report 117
Natural phosphodiesterase 5 (PDE5) inhibitors: a computational approach 116
Unfolded p53: a potential biomarker for Alzheimer's disease 115
Dopamine inhibition of neurotensin-induced increase in Ca2+ influx into rat pituitary cells. 115
Using iPS cells toward the understanding of parkinson'€™s disease 115
Carbon on poly(ε-caprolactone) (PCL) ink-jet printed sensor for monitoring cell cultures of myoblasts 114
Glutathionylation of the pro-apoptotic protein p53 in Alzheimer's disease brain: implications for AD pathogenesis 113
Alzheimer's disease: new diagnostic and therapeutic tools. 113
Inhibition of glutamate-induced neurotoxicity by a tau antisense oligonucleotide in primary culture of rat cerebellar granule cells 112
Acute hemodynamic effects of the two dopaminergic agonists ibopamine and dihydroergotamine, a comparison with the parent compound. 111
Importance and Difficulties in the Use of Chiroptical Methods to Assign the Absolute Configuration of Natural Products: The Case of Phytotoxic Pyrones and Furanones Produced by Diplodia corticola 111
Activation of multiple metabotropic glutamate receptor subtypes prevents NMDA-induced excitotoxicity in rat hippocampal slices. 111
Antisense strategy unravels a dopamine receptor distinct from the D2 subtype, uncoupled with adenylyl cyclase, inhibiting prolactin release from rat pituitary cells 110
Cannabidiol: Recent advances and new insights for neuropsychiatric disorders treatment 110
Pharmacological basis for dopamine D-2 receptor diversity 109
D2 dopamine receptors associated with inhibition of dopamine release from rat neostriatum are independent of cyclic AMP. 109
Zebrafish embryo as an in vivo model for behavioral and pharmacological characterization of methylxanthine drugs 109
Behavioral abnormalities in the Fmr1-KO2 mouse model of fragile X syndrome: The relevance of early life phases 109
Tau protein immunolocalization in fetal and adult human spinal cord. 108
Induction of tumour-suppressor phosphoprotein p53 in the apoptosis of cultured rat cerebellar neurones triggered by excitatory amino acids. 108
Activation of cell-cycle-associated proteins in neuronal death: a mandatory or dispensable path? 108
Dopamine receptors are present in rat and human esophagus 107
Identification of neurotensin receptors associated with calcium channels and prolactin release in rat pituitary. 106
Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells. 106
Metabotropic glutamate receptor mRNA expression in rat spinal cord 106
Opposing regulation of tau protein levels by ionotropic and metabotropic glutamate receptors in human NT2 neurons 105
Acute scopolamine treatment decreases dopamine metabolism in rat hippocampus and frontal cortex 105
Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall? 105
Tolerance to hypoactivity and sensitization to hyperactivity after chronic treatment with a presynaptic dose of lisuride in rats 105
Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference 105
Transcriptional pharmacology of neurodegenerative disorders: novel venue towards neuroprotection against excitotoxicity? 104
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: Implications for personalized cancer therapy 104
Computational and functional analysis of biopharmaceutical drugs in zebrafish: Erythropoietin as a test model 104
Down-regulation of coasy, the gene associated with NBIA-VI, reduces Bmp signaling, perturbs dorso-ventral patterning and alters neuronal development in zebrafish 104
Alzheimer's disease: new diagnostic and therapeutic tools. 103
Why do centenarians escape or postpone cancer? The role of IGF-1, inflammation and p53 103
Evidence for the presence of D1 and D2 dopamine receptors in the rat adrenal cortex 103
Chronic lead exposure alters dopaminergic mechanisms in rat pituitary 103
Vasoactive Intestinal Polypeptide (VIP) selectively stimulates prolactin release in healthy women 103
Dopaminergic inhibition of prolactin release and calcium influx induced by neurotensin in anterior pituitary is independent of cyclic AMP system. 103
Tau protein immunolocalization in fetal and adult human spinal cord. 103
Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancers 103
Increased CD44 gene expression in lymphocytes derived from Alzheimer disease patients. 102
Cocaine-induced supersensitivity of striatal dopamine receptors: role of endogenous calmodulin. 102
Totale 14.885
Categoria #
all - tutte 148.333
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 148.333


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.741 0 358 400 1.140 627 1.135 982 1.065 779 1.347 354 554
2020/20216.235 145 702 258 741 295 644 312 695 781 566 788 308
2021/20223.284 321 627 81 141 37 114 222 194 125 434 296 692
2022/20232.478 434 96 76 182 193 642 17 241 367 49 88 93
2023/20242.721 156 81 238 157 129 466 127 104 694 95 34 440
2024/202595 55 40 0 0 0 0 0 0 0 0 0 0
Totale 33.916